|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lymphoma | |||||
| Breast Neoplasms | |||||
| Lung Neoplasms | |||||
| Multiple Myeloma | |||||
| Chronic Lymphocytic Leukemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia | |||||
| Leukemia, B-Cell | |||||
| Leukemia, Lymphocytic, Chronic, B-Cell | |||||
| Leukemia, Lymphoid | |||||
| Neoplasms | |||||
| Neoplasms, Plasma Cell | |||||
| 3 | More general conditions related to this trial | ||||
| Blood Protein Disorders | |||||
| Breast Diseases | |||||
| Cardiovascular Diseases | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Hemostatic Disorders | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lung Diseases | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Paraproteinemias | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Skin Diseases | |||||
| Thoracic Neoplasms | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| darbepoetin alfa | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Amgen | |||||